Sort by
Refine Your Search
-
private philanthropic support by identifying targeted alumni, friends, and constituent engagement opportunities and providing excellent stewardship of donors. The Assistant Dean will work with colleagues
-
experiences. For candidates who hold or will hold a bachelor’s degree by December 31, 2025, the targeted start date is January 2026. For those graduating in May 2026, the targeted start date is in June 2026
-
schedule of unit rotations and projects that align with the Accounting Fellow’s interests, strengths, and experiences. For candidates who will hold a bachelor’s degree by December 31, 2025, the targeted
-
and projects that align with the Accounting Fellow’s interests, strengths, and experiences. For candidates who will hold a bachelor’s degree by December 31, 2025, the targeted start date is January 2026
-
the college's advancement program, which recently achieved $20M per year in new gifts and commitments. The assistant dean will lead a team focused on securing private philanthropic support by identifying targeted
-
to target, recruit, and enroll students in undergraduate degree programs. Depending on experience and qualifications, this role will join the office as Senior Assistant Director or Associate Director. The
-
associated bone marrow failure and its role in clonal selection 3. Clonal evolution and therapeutic vulnerabilities: using single cell sequencing to track clonal dynamics and to identify targets in high risk
-
provide current research based information to citizens by employing various delivery methods targeted to broad audiences; works closely with producers, agribusiness, community leaders, Extension Leadership
-
various delivery methods targeted to broad audiences; works closely with producers, agribusiness, community leaders, Extension Leadership Councils and appropriate agents and specialists to identify and
-
understanding its contribution to clonal selection. 3. Clonal evolution and therapeutic vulnerabilities: Using single-cell sequencing platforms to track clonal evolution and identify novel therapeutic targets in